Serial changes in plasma ketone concentrations in patients with acute brain injury

Hayden White, Balasubramanian Venkatesh, Mark Jones, Hesly Fuentes

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)
8 Downloads (Pure)

Abstract

Objective: Acute brain injury (ABI) is a catastrophic event, leading to disruption of the normal cerebral metabolic pathways and a subsequent cerebral energy deficit. Ketones (beta-hydroxybutyrate (BHB) and acetoacetate) may represent an alternative metabolic substrate with the potential to improve cerebral energy supply and decrease injury. The purpose of this study was to evaluate baseline ketone concentrations in the ABI population. Methods: Thirty-eight patients with ABI were enrolled into the study and followed for up to 7 days. We collected arterial blood samples immediately after admission and daily to measure the levels of BHB and acetoacetate. Where possible, matching cerebrospinal fluid (CSF) specimens were also collected. Results: During the study period, plasma BHB levels were increased initially but normalized by day 3 while acetoacetate levels remained within the normal range. The change in BHB was significant. There were 30 observations in 10 patients where BHB could be measured in both blood and CSF. When the data were averaged over patients there was a weak correlation between blood and CSF BHB (Spearman’s ρ = 0.62, p = 0.054). Conclusion: Blood ketone concentrations remain low within the ABI population. An external source of ketones will be required to increase blood concentrations to clinically relevant levels.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalNeurological Research
Volume39
Issue number1
Early online date27 Oct 2016
DOIs
Publication statusPublished - 2 Jan 2017
Externally publishedYes

Fingerprint

3-Hydroxybutyric Acid
Ketones
Brain Injuries
Cerebrospinal Fluid
Metabolic Networks and Pathways
Population
Reference Values
Wounds and Injuries
acetoacetic acid

Cite this

White, Hayden ; Venkatesh, Balasubramanian ; Jones, Mark ; Fuentes, Hesly. / Serial changes in plasma ketone concentrations in patients with acute brain injury. In: Neurological Research. 2017 ; Vol. 39, No. 1. pp. 1-6.
@article{d0687bb3d75f4a13a1f5c8cba36c883a,
title = "Serial changes in plasma ketone concentrations in patients with acute brain injury",
abstract = "Objective: Acute brain injury (ABI) is a catastrophic event, leading to disruption of the normal cerebral metabolic pathways and a subsequent cerebral energy deficit. Ketones (beta-hydroxybutyrate (BHB) and acetoacetate) may represent an alternative metabolic substrate with the potential to improve cerebral energy supply and decrease injury. The purpose of this study was to evaluate baseline ketone concentrations in the ABI population. Methods: Thirty-eight patients with ABI were enrolled into the study and followed for up to 7 days. We collected arterial blood samples immediately after admission and daily to measure the levels of BHB and acetoacetate. Where possible, matching cerebrospinal fluid (CSF) specimens were also collected. Results: During the study period, plasma BHB levels were increased initially but normalized by day 3 while acetoacetate levels remained within the normal range. The change in BHB was significant. There were 30 observations in 10 patients where BHB could be measured in both blood and CSF. When the data were averaged over patients there was a weak correlation between blood and CSF BHB (Spearman’s ρ = 0.62, p = 0.054). Conclusion: Blood ketone concentrations remain low within the ABI population. An external source of ketones will be required to increase blood concentrations to clinically relevant levels.",
author = "Hayden White and Balasubramanian Venkatesh and Mark Jones and Hesly Fuentes",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/01616412.2016.1251695",
language = "English",
volume = "39",
pages = "1--6",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "1",

}

Serial changes in plasma ketone concentrations in patients with acute brain injury. / White, Hayden; Venkatesh, Balasubramanian; Jones, Mark; Fuentes, Hesly.

In: Neurological Research, Vol. 39, No. 1, 02.01.2017, p. 1-6.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Serial changes in plasma ketone concentrations in patients with acute brain injury

AU - White, Hayden

AU - Venkatesh, Balasubramanian

AU - Jones, Mark

AU - Fuentes, Hesly

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Objective: Acute brain injury (ABI) is a catastrophic event, leading to disruption of the normal cerebral metabolic pathways and a subsequent cerebral energy deficit. Ketones (beta-hydroxybutyrate (BHB) and acetoacetate) may represent an alternative metabolic substrate with the potential to improve cerebral energy supply and decrease injury. The purpose of this study was to evaluate baseline ketone concentrations in the ABI population. Methods: Thirty-eight patients with ABI were enrolled into the study and followed for up to 7 days. We collected arterial blood samples immediately after admission and daily to measure the levels of BHB and acetoacetate. Where possible, matching cerebrospinal fluid (CSF) specimens were also collected. Results: During the study period, plasma BHB levels were increased initially but normalized by day 3 while acetoacetate levels remained within the normal range. The change in BHB was significant. There were 30 observations in 10 patients where BHB could be measured in both blood and CSF. When the data were averaged over patients there was a weak correlation between blood and CSF BHB (Spearman’s ρ = 0.62, p = 0.054). Conclusion: Blood ketone concentrations remain low within the ABI population. An external source of ketones will be required to increase blood concentrations to clinically relevant levels.

AB - Objective: Acute brain injury (ABI) is a catastrophic event, leading to disruption of the normal cerebral metabolic pathways and a subsequent cerebral energy deficit. Ketones (beta-hydroxybutyrate (BHB) and acetoacetate) may represent an alternative metabolic substrate with the potential to improve cerebral energy supply and decrease injury. The purpose of this study was to evaluate baseline ketone concentrations in the ABI population. Methods: Thirty-eight patients with ABI were enrolled into the study and followed for up to 7 days. We collected arterial blood samples immediately after admission and daily to measure the levels of BHB and acetoacetate. Where possible, matching cerebrospinal fluid (CSF) specimens were also collected. Results: During the study period, plasma BHB levels were increased initially but normalized by day 3 while acetoacetate levels remained within the normal range. The change in BHB was significant. There were 30 observations in 10 patients where BHB could be measured in both blood and CSF. When the data were averaged over patients there was a weak correlation between blood and CSF BHB (Spearman’s ρ = 0.62, p = 0.054). Conclusion: Blood ketone concentrations remain low within the ABI population. An external source of ketones will be required to increase blood concentrations to clinically relevant levels.

UR - http://www.scopus.com/inward/record.url?scp=84992524326&partnerID=8YFLogxK

U2 - 10.1080/01616412.2016.1251695

DO - 10.1080/01616412.2016.1251695

M3 - Article

VL - 39

SP - 1

EP - 6

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 1

ER -